BIOGEN INC. - FORM 10-Q - EX-32.1 - EX-32.1 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 - April 20, 2010

Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - BIOGEN INC.Financial_Report.xls
10-Q - BIOGEN IDEC INC. - BIOGEN INC.b79987e10vq.htm
EX-31.1 - EX-31.1 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 - BIOGEN INC.b79987exv31w1.htm
EX-10.3 - EX-10.3 BIOGEN IDEC INC. 2006 NON-EMPLOYEE DIRECTORS EQUITY PLAN, AS AMENDED. - BIOGEN INC.b79987exv10w3.htm
EX-10.2 - EX-10.2 FORM OF MARKET STOCK UNIT AWARD AGREEMENT UNDER THE 2008 OMNIBUS EQUITY PLAN - BIOGEN INC.b79987exv10w2.htm
EX-10.1 - EX-10.1 FORM OF CASH-SETTLED PERFORMANCE SHARES AWARD AGREEMENT UNDER THE 2008 OMNIBUS EQUITY PLAN - BIOGEN INC.b79987exv10w1.htm
EX-31.2 - EX-31.2 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 - BIOGEN INC.b79987exv31w2.htm
EXHIBIT 32.1
CERTIFICATION
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
     Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Biogen Idec Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
     The Quarterly Report on Form 10-Q for the quarter ended March 31, 2010 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
         
     
Dated: April 20, 2010  /s/ James C. Mullen    
  James C. Mullen   
  Chief Executive Officer and President
[principal executive officer] 		  
 
     
Dated: April 20, 2010  /s/ Paul J. Clancy    
  Paul J. Clancy   
  Executive Vice President and Chief Financial Officer
[principal financial officer] 		  
 
     A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

Stock widget

Investing forum

BIOGEN INC. Reports